Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
IMC-I109V, a novel T cell receptor (TCR) bispecific (ENVxCD3) designed to eliminate HBV-infected hepatocytes in chronic HBV patients: initial data from a first-in-human study. Poster Presentation (SAT437) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology | 2022 |